HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in breast cancer and some other types of cancer, such as gastric (stomach) cancer. HER2 stands for Human Epidermal Growth Factor Receptor 2, which is a gene that encodes a protein receptor on the surface of certain cells, including breast cells. HER2 status is an important factor in determining treatment options and predicting the prognosis for individuals with specific types of cancer.

The global HER2 Tumor Marker Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global market for HER2 Tumor Marker Testing has been experiencing steady growth. This growth is primarily driven by the increasing incidence of breast cancer and the importance of HER2 status in determining treatment decisions. The market size is influenced by factors such as population aging, awareness of breast cancer screening, and advancements in diagnostic techniques. North America, particularly the United States, is a significant market for HER2 Tumor Marker Testing. The region has well-established breast cancer screening and diagnosis programs. The adoption of targeted therapies, such as Herceptin, has been prominent in this region. Europe also has a substantial market for HER2 testing, with countries like the United Kingdom, Germany, and France being key contributors. The European market is characterized by a growing emphasis on early cancer detection and personalized medicine. The Asia-Pacific region, including countries like China and India, offers growth opportunities. The increasing healthcare spending, growing awareness of breast cancer, and rising population contribute to market expansion.

This report aims to provide a comprehensive presentation of the global market for HER2 Tumor Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Tumor Marker Testing.

Report Scope

The HER2 Tumor Marker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HER2 Tumor Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HER2 Tumor Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HER2 Tumor Marker Testing Market Report

Report Metric	Details
Report Name	HER2 Tumor Marker Testing Market
Segment by Type	Immunohistochemistry (IHC) Fluorescence In Situ Hybridization (FISH) Silver In Situ Hybridization (SISH) Others
Segment by Application	Hospitals Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Roche, Thermo Fisher Scientific, Agilent, Leica Biosystems, Biocare Medical, BioGenex, Sysmex, Abnova, Novartis, InvivoGen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Tumor Marker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HER2 Tumor Marker Testing Market report?

Ans: The main players in the HER2 Tumor Marker Testing Market are Abbott, Roche, Thermo Fisher Scientific, Agilent, Leica Biosystems, Biocare Medical, BioGenex, Sysmex, Abnova, Novartis, InvivoGen

What are the Application segmentation covered in the HER2 Tumor Marker Testing Market report?

Ans: The Applications covered in the HER2 Tumor Marker Testing Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the HER2 Tumor Marker Testing Market report?

Ans: The Types covered in the HER2 Tumor Marker Testing Market report are Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), Silver In Situ Hybridization (SISH), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HER2 Tumor Marker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunohistochemistry (IHC)

1.2.3 Fluorescence In Situ Hybridization (FISH)

1.2.4 Silver In Situ Hybridization (SISH)

1.2.5 Others

1.3 Market by Application

1.3.1 Global HER2 Tumor Marker Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global HER2 Tumor Marker Testing Market Perspective (2019-2030)

2.2 HER2 Tumor Marker Testing Growth Trends by Region

2.2.1 Global HER2 Tumor Marker Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 HER2 Tumor Marker Testing Historic Market Size by Region (2019-2024)

2.2.3 HER2 Tumor Marker Testing Forecasted Market Size by Region (2025-2030)

2.3 HER2 Tumor Marker Testing Market Dynamics

2.3.1 HER2 Tumor Marker Testing Industry Trends

2.3.2 HER2 Tumor Marker Testing Market Drivers

2.3.3 HER2 Tumor Marker Testing Market Challenges

2.3.4 HER2 Tumor Marker Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HER2 Tumor Marker Testing Players by Revenue

3.1.1 Global Top HER2 Tumor Marker Testing Players by Revenue (2019-2024)

3.1.2 Global HER2 Tumor Marker Testing Revenue Market Share by Players (2019-2024)

3.2 Global HER2 Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by HER2 Tumor Marker Testing Revenue

3.4 Global HER2 Tumor Marker Testing Market Concentration Ratio

3.4.1 Global HER2 Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HER2 Tumor Marker Testing Revenue in 2023

3.5 HER2 Tumor Marker Testing Key Players Head office and Area Served

3.6 Key Players HER2 Tumor Marker Testing Product Solution and Service

3.7 Date of Enter into HER2 Tumor Marker Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 HER2 Tumor Marker Testing Breakdown Data by Type

4.1 Global HER2 Tumor Marker Testing Historic Market Size by Type (2019-2024)

4.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2025-2030)

5 HER2 Tumor Marker Testing Breakdown Data by Application

5.1 Global HER2 Tumor Marker Testing Historic Market Size by Application (2019-2024)

5.2 Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America HER2 Tumor Marker Testing Market Size (2019-2030)

6.2 North America HER2 Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America HER2 Tumor Marker Testing Market Size by Country (2019-2024)

6.4 North America HER2 Tumor Marker Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HER2 Tumor Marker Testing Market Size (2019-2030)

7.2 Europe HER2 Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe HER2 Tumor Marker Testing Market Size by Country (2019-2024)

7.4 Europe HER2 Tumor Marker Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HER2 Tumor Marker Testing Market Size (2019-2030)

8.2 Asia-Pacific HER2 Tumor Marker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HER2 Tumor Marker Testing Market Size (2019-2030)

9.2 Latin America HER2 Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America HER2 Tumor Marker Testing Market Size by Country (2019-2024)

9.4 Latin America HER2 Tumor Marker Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HER2 Tumor Marker Testing Market Size (2019-2030)

10.2 Middle East & Africa HER2 Tumor Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott HER2 Tumor Marker Testing Introduction

11.1.4 Abbott Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche HER2 Tumor Marker Testing Introduction

11.2.4 Roche Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Detail

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific HER2 Tumor Marker Testing Introduction

11.3.4 Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Agilent

11.4.1 Agilent Company Detail

11.4.2 Agilent Business Overview

11.4.3 Agilent HER2 Tumor Marker Testing Introduction

11.4.4 Agilent Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.4.5 Agilent Recent Development

11.5 Leica Biosystems

11.5.1 Leica Biosystems Company Detail

11.5.2 Leica Biosystems Business Overview

11.5.3 Leica Biosystems HER2 Tumor Marker Testing Introduction

11.5.4 Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.5.5 Leica Biosystems Recent Development

11.6 Biocare Medical

11.6.1 Biocare Medical Company Detail

11.6.2 Biocare Medical Business Overview

11.6.3 Biocare Medical HER2 Tumor Marker Testing Introduction

11.6.4 Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.6.5 Biocare Medical Recent Development

11.7 BioGenex

11.7.1 BioGenex Company Detail

11.7.2 BioGenex Business Overview

11.7.3 BioGenex HER2 Tumor Marker Testing Introduction

11.7.4 BioGenex Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.7.5 BioGenex Recent Development

11.8 Sysmex

11.8.1 Sysmex Company Detail

11.8.2 Sysmex Business Overview

11.8.3 Sysmex HER2 Tumor Marker Testing Introduction

11.8.4 Sysmex Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.8.5 Sysmex Recent Development

11.9 Abnova

11.9.1 Abnova Company Detail

11.9.2 Abnova Business Overview

11.9.3 Abnova HER2 Tumor Marker Testing Introduction

11.9.4 Abnova Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.9.5 Abnova Recent Development

11.10 Novartis

11.10.1 Novartis Company Detail

11.10.2 Novartis Business Overview

11.10.3 Novartis HER2 Tumor Marker Testing Introduction

11.10.4 Novartis Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.10.5 Novartis Recent Development

11.11 InvivoGen

11.11.1 InvivoGen Company Detail

11.11.2 InvivoGen Business Overview

11.11.3 InvivoGen HER2 Tumor Marker Testing Introduction

11.11.4 InvivoGen Revenue in HER2 Tumor Marker Testing Business (2019-2024)

11.11.5 InvivoGen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Roche

Thermo Fisher Scientific

List of Tables

Table 1. Global HER2 Tumor Marker Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunohistochemistry (IHC)

Table 3. Key Players of Fluorescence In Situ Hybridization (FISH)

Table 4. Key Players of Silver In Situ Hybridization (SISH)

Table 5. Key Players of Others

Table 6. Global HER2 Tumor Marker Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global HER2 Tumor Marker Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global HER2 Tumor Marker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global HER2 Tumor Marker Testing Market Share by Region (2019-2024)

Table 10. Global HER2 Tumor Marker Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global HER2 Tumor Marker Testing Market Share by Region (2025-2030)

Table 12. HER2 Tumor Marker Testing Market Trends

Table 13. HER2 Tumor Marker Testing Market Drivers

Table 14. HER2 Tumor Marker Testing Market Challenges

Table 15. HER2 Tumor Marker Testing Market Restraints

Table 16. Global HER2 Tumor Marker Testing Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global HER2 Tumor Marker Testing Market Share by Players (2019-2024)

Table 18. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2023)

Table 19. Ranking of Global Top HER2 Tumor Marker Testing Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by HER2 Tumor Marker Testing Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players HER2 Tumor Marker Testing Product Solution and Service

Table 23. Date of Enter into HER2 Tumor Marker Testing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global HER2 Tumor Marker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2019-2024)

Table 27. Global HER2 Tumor Marker Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global HER2 Tumor Marker Testing Revenue Market Share by Type (2025-2030)

Table 29. Global HER2 Tumor Marker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2019-2024)

Table 31. Global HER2 Tumor Marker Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global HER2 Tumor Marker Testing Revenue Market Share by Application (2025-2030)

Table 33. North America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America HER2 Tumor Marker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America HER2 Tumor Marker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe HER2 Tumor Marker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe HER2 Tumor Marker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific HER2 Tumor Marker Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific HER2 Tumor Marker Testing Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America HER2 Tumor Marker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America HER2 Tumor Marker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa HER2 Tumor Marker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa HER2 Tumor Marker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 48. Abbott Company Detail

Table 49. Abbott Business Overview

Table 50. Abbott HER2 Tumor Marker Testing Product

Table 51. Abbott Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 52. Abbott Recent Development

Table 53. Roche Company Detail

Table 54. Roche Business Overview

Table 55. Roche HER2 Tumor Marker Testing Product

Table 56. Roche Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Thermo Fisher Scientific Company Detail

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific HER2 Tumor Marker Testing Product

Table 61. Thermo Fisher Scientific Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. Agilent Company Detail

Table 64. Agilent Business Overview

Table 65. Agilent HER2 Tumor Marker Testing Product

Table 66. Agilent Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 67. Agilent Recent Development

Table 68. Leica Biosystems Company Detail

Table 69. Leica Biosystems Business Overview

Table 70. Leica Biosystems HER2 Tumor Marker Testing Product

Table 71. Leica Biosystems Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 72. Leica Biosystems Recent Development

Table 73. Biocare Medical Company Detail

Table 74. Biocare Medical Business Overview

Table 75. Biocare Medical HER2 Tumor Marker Testing Product

Table 76. Biocare Medical Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 77. Biocare Medical Recent Development

Table 78. BioGenex Company Detail

Table 79. BioGenex Business Overview

Table 80. BioGenex HER2 Tumor Marker Testing Product

Table 81. BioGenex Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 82. BioGenex Recent Development

Table 83. Sysmex Company Detail

Table 84. Sysmex Business Overview

Table 85. Sysmex HER2 Tumor Marker Testing Product

Table 86. Sysmex Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 87. Sysmex Recent Development

Table 88. Abnova Company Detail

Table 89. Abnova Business Overview

Table 90. Abnova HER2 Tumor Marker Testing Product

Table 91. Abnova Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 92. Abnova Recent Development

Table 93. Novartis Company Detail

Table 94. Novartis Business Overview

Table 95. Novartis HER2 Tumor Marker Testing Product

Table 96. Novartis Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 97. Novartis Recent Development

Table 98. InvivoGen Company Detail

Table 99. InvivoGen Business Overview

Table 100. InvivoGen HER2 Tumor Marker Testing Product

Table 101. InvivoGen Revenue in HER2 Tumor Marker Testing Business (2019-2024) & (US$ Million)

Table 102. InvivoGen Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HER2 Tumor Marker Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global HER2 Tumor Marker Testing Market Share by Type: 2023 VS 2030

Figure 3. Immunohistochemistry (IHC) Features

Figure 4. Fluorescence In Situ Hybridization (FISH) Features

Figure 5. Silver In Situ Hybridization (SISH) Features

Figure 6. Others Features

Figure 7. Global HER2 Tumor Marker Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global HER2 Tumor Marker Testing Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. HER2 Tumor Marker Testing Report Years Considered

Figure 13. Global HER2 Tumor Marker Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global HER2 Tumor Marker Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global HER2 Tumor Marker Testing Market Share by Region: 2023 VS 2030

Figure 16. Global HER2 Tumor Marker Testing Market Share by Players in 2023

Figure 17. Global Top HER2 Tumor Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Tumor Marker Testing as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by HER2 Tumor Marker Testing Revenue in 2023

Figure 19. North America HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America HER2 Tumor Marker Testing Market Share by Country (2019-2030)

Figure 21. United States HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe HER2 Tumor Marker Testing Market Share by Country (2019-2030)

Figure 25. Germany HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific HER2 Tumor Marker Testing Market Share by Region (2019-2030)

Figure 33. China HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America HER2 Tumor Marker Testing Market Share by Country (2019-2030)

Figure 41. Mexico HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa HER2 Tumor Marker Testing Market Share by Country (2019-2030)

Figure 45. Turkey HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia HER2 Tumor Marker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Abbott Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 48. Roche Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 50. Agilent Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 51. Leica Biosystems Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 52. Biocare Medical Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 53. BioGenex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 54. Sysmex Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 55. Abnova Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 56. Novartis Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 57. InvivoGen Revenue Growth Rate in HER2 Tumor Marker Testing Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Oncology Imaging Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1U15802

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global HER2 Tumor Marker Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27D15553

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Targeted Radiotherapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2U15903

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2W15676

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions